Info

BioSphere Medical, Inc. (BioSphere) develops, manufactures and markets products for medical procedures using embolotherapy techniques. The Company’s technologies consist of patented bioengineered polymers, which are chemical compounds that it creates through the application to medical science of engineering principles and manufacturing methods. These core technologies are used to produce miniature spherical embolic particles with beneficial properties for a range of medical applications. The Company’s principal focus is the treatment of symptomatic uterine fibroids, which are non-cancerous (benign) tumors growing within or on the wall of the uterus, using a procedure called uterine fibroid embolization (UFE). BioSphere Medical, Embosphere, EmboGold, EmboCath, Segway, EmboCath Plus, Sequitor, HepaSphere, QuadraSphere, ask4UFE.com and Passthru are trademarks of BioSphere Medical, Inc.(Source: 10-K)